ClinVar Miner

Submissions for variant NM_000372.5(TYR):c.307T>C (p.Cys103Arg)

dbSNP: rs1482829698
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Center for Human Genetics Tuebingen RCV000512841 SCV000608612 likely pathogenic not provided 2017-04-30 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003317249 SCV004020591 likely pathogenic Oculocutaneous albinism 2023-06-20 criteria provided, single submitter clinical testing Variant summary: TYR c.307T>C (p.Cys103Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251290 control chromosomes (gnomAD). c.307T>C has been reported in the literature in individuals affected with Oculocutaneous Albinism (e.g., Wang_2018, Lasseaux_2018). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. At least one other variant affecting the same amino acid residue (c.308G>A, p.Cys103Tyr) has been reported in multiple affected patients/families and has been determined to be on the pathogenic spectrum (PMIDs: 29345414, 30996339, 32552135). The following publications have been ascertained in the context of this evaluation (PMID: 29345414, 30341532). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Invitae RCV000512841 SCV004280474 pathogenic not provided 2023-11-06 criteria provided, single submitter clinical testing This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 103 of the TYR protein (p.Cys103Arg). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with culocutaneous albinism (PMID: 29345414, 30341532). ClinVar contains an entry for this variant (Variation ID: 444269). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 80%. This variant disrupts the p.Cys103 amino acid residue in TYR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29345414, 30996339). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.